138 related articles for article (PubMed ID: 22968075)
41. Importance of lymph node metastases in follicular thyroid cancer.
Witte J; Goretzki PE; Dieken J; Simon D; Röher HD
World J Surg; 2002 Aug; 26(8):1017-22. PubMed ID: 12045860
[TBL] [Abstract][Full Text] [Related]
42. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
[TBL] [Abstract][Full Text] [Related]
44. Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome.
Alzumaili B; Xu B; Spanheimer PM; Tuttle RM; Sherman E; Katabi N; Dogan S; Ganly I; Untch BR; Ghossein RA
Mod Pathol; 2020 Sep; 33(9):1690-1701. PubMed ID: 32313184
[TBL] [Abstract][Full Text] [Related]
45. [Prognostic value of clinical, histopathological and immunohistochemical features in medullary thyroid cancer].
Ríos A; Rodríguez JM; Febrero B; Acosta JM; Torregrosa N; Parrilla P
Med Clin (Barc); 2012 Sep; 139(7):277-83. PubMed ID: 22032817
[TBL] [Abstract][Full Text] [Related]
46. SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival.
de Vries LH; Lodewijk L; Willems SM; Dreijerink KMA; de Keizer B; van Diest PJ; Schepers A; Bonenkamp HJ; van Engen-van Grunsven IACH; Kruijff S; van Hemel BM; Links TP; Nieveen van Dijkum EJM; van Eeden S; Valk GD; Borel Rinkes IHM; Vriens MR
Endocrine; 2018 Dec; 62(3):639-647. PubMed ID: 30128959
[TBL] [Abstract][Full Text] [Related]
47. Response to initial therapy predicts clinical outcomes in medullary thyroid cancer.
Lindsey SC; Ganly I; Palmer F; Tuttle RM
Thyroid; 2015 Feb; 25(2):242-9. PubMed ID: 25338223
[TBL] [Abstract][Full Text] [Related]
48. Markov model-based estimation of individual survival probability for medullary thyroid cancer patients.
Esik O; Tusnády G; Trón L; Boér A; Szentirmay Z; Szabolcs I; Rácz K; Lengyel E; Székely J; Kásler M
Pathol Oncol Res; 2002; 8(2):93-104. PubMed ID: 12172572
[TBL] [Abstract][Full Text] [Related]
49. Nasopharyngeal carcinoma: the significance of neck node involvement in relation to the pattern of distant failure.
Sham JS; Choy D; Choi PH
Br J Radiol; 1990 Feb; 63(746):108-13. PubMed ID: 2310902
[TBL] [Abstract][Full Text] [Related]
50. Four patients with cutaneous metastases from medullary thyroid cancer.
Santarpia L; El-Naggar AK; Sherman SI; Hymes SR; Gagel RF; Shaw S; Sarlis NJ
Thyroid; 2008 Aug; 18(8):901-5. PubMed ID: 18651821
[TBL] [Abstract][Full Text] [Related]
51. Tumor protein p53-induced nuclear protein (TP53INP1) expression in medullary thyroid carcinoma: a molecular guide to the optimal extent of surgery?
Taïeb D; Giusiano S; Sebag F; Marcy M; de Micco C; Palazzo FF; Dusetti NJ; Iovanna JL; Henry JF; Garcia S; Taranger-Charpin C
World J Surg; 2010 Apr; 34(4):830-5. PubMed ID: 20145930
[TBL] [Abstract][Full Text] [Related]
52. Competing-risks model for predicting the prognostic value of lymph nodes in medullary thyroid carcinoma.
Shang F; Liu X; Ren X; Li Y; Cai L; Sun Y; Wen J; Zhai X
PLoS One; 2023; 18(10):e0292488. PubMed ID: 37844021
[TBL] [Abstract][Full Text] [Related]
53. Synchronous lung and liver metastases from medullary thyroid carcinoma.
Yanardag H; Tetikkurt C; Tetikkurt S
Can Respir J; 2003; 10(1):39-41. PubMed ID: 12624620
[TBL] [Abstract][Full Text] [Related]
54. Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer.
Machens A; Hauptmann S; Dralle H
World J Surg; 2007 Oct; 31(10):1960-5. PubMed ID: 17665245
[TBL] [Abstract][Full Text] [Related]
55. Desmoplastic stromal reaction in medullary thyroid cancer-an intraoperative "marker" for lymph node metastases.
Scheuba C; Kaserer K; Kaczirek K; Asari R; Niederle B
World J Surg; 2006 May; 30(5):853-9. PubMed ID: 16680600
[TBL] [Abstract][Full Text] [Related]
56. Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients.
Machens A; Dralle H
Eur J Surg Oncol; 2005 Nov; 31(9):1051-2. PubMed ID: 15908165
[No Abstract] [Full Text] [Related]
57. A Novel N Staging System for Predicting Survival in Patients with Medullary Thyroid Cancer.
Chen L; Qian K; Guo K; Zheng X; Sun W; Sun T; Wang Y; Li D; Wu Y; Ji Q; Wang Z
Ann Surg Oncol; 2019 Dec; 26(13):4430-4438. PubMed ID: 31552613
[TBL] [Abstract][Full Text] [Related]
58. Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients.
Szavcsur P; Godény M; Bajzik G; Lengyel E; Repa I; Trón L; Boér A; Vincze B; Póti Z; Szabolcs I; Esik O
Eur J Surg Oncol; 2005 Mar; 31(2):183-90. PubMed ID: 15698736
[TBL] [Abstract][Full Text] [Related]
59. Thyroid carcinoma invading the cervicovisceral axis: routes of invasion and clinical implications.
Machens A; Hinze R; Lautenschläger C; Thomusch O; Dralle H
Surgery; 2001 Jan; 129(1):23-8. PubMed ID: 11150030
[TBL] [Abstract][Full Text] [Related]
60. TNM classification of thyroid carcinoma.
Shaha AR
World J Surg; 2007 May; 31(5):879-87. PubMed ID: 17308849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
